Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer

Autor: Cavalieri, S., Perrone, F., Miceli, R., Ascierto, P.A., Locati, L.D., Bergamini, C., Granata, R., Alfieri, S., Resteghini, C., Galbiati, D., Busico, A., Paielli, N., Patuzzo, R., Maurichi, A., Gallino, G., Ruggeri, R., Mariani, L., Palla, M., Licitra, L., Bossi, P.
Zdroj: In European Journal of Cancer July 2018 97:7-15
Databáze: ScienceDirect